Yıl: 2022 Cilt: 33 Sayı: 10 Sayfa Aralığı: 822 - 830 Metin Dili: İngilizce DOI: 10.5152/tjg.2022.21550 İndeks Tarihi: 25-10-2022

Probiotics in Experimental Ulcerative Colitis: Mast Cell Density and Neuronal Hypertrophy

Öz:
Background: Probiotics such as Lactobacillus and Bifidobacterium are among the supportive treatment methods to achieve effective results in ulcerative colitis. This study was established to investigate the effect of probiotics in experimental ulcerative colitis and to detect changes in mast cell and neuronal structures in this treatment method. Methods: A total of 48 adult male rats were used to study the effects of probiotics on ulcerative colitis. The animals were divided into 6 groups as control, experimental colitis, and four probiotic protective groups. Three different bacterial strains were administered to the protective groups individually and in combination by gavage. PGP 9.5 antibody and mast cell tryptase were used for the detection of neuronal structures and mast cells. The number of Schwann cells and ganglia, size measurements of ganglia, and density of mast cells were evaluated. Results: Compared to the control, an increase in the number of mast cells was detected in all groups. Especially the increase in the number of mast cells was found to be statistically significant in combined probiotic administration. In the detection of neuronal structures, a significant increase in the number of Schwann cells and ganglia was detected in groups where probiotics were administered combined and individually. Conclusion: These results suggest that probiotics may play a role in the supporting effect of increasing the number of mast cells and neuronal structures, protecting the intestinal wall. We think that more specific and detailed studies should be conducted to evaluate the protective/therapeutic effect of probiotics in future studies.Anatomi Anabilim Dalı, Akdeniz Üniversitesi Tıp Fakültesi, Antalya, Türkiye
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Yang Y, Zhu X, Qin Y, et al. The anti-inflammatory effect of Guchangzhixie-pill by reducing colonic EC cell hyperplasia and serotonin availability in an ulcerative colitis rat model. Evid Based Complement Alternat Med. 2017;2017:8547257. [CrossRef]
  • 2. Stoyanova II, Gulubova MV. Mast cells and inflammatory mediators in chronic ulcerative colitis. Acta Histochem. 2002;104(2):185- 192. [CrossRef]
  • 3. Andoh A, Deguchi Y, Inatomi O, et al. Immunohistochemical study of chymase-positive mast cells in inflammatory bowel disease. Oncol Rep. 2006;16(1):103-107. [CrossRef]
  • 4. Sasaki Y, Tanaka M, Kudo H. Differentiation between ulcerative colitis and Crohn’s disease by a quantitative immunohistochemical evaluation of T lymphocytes, neutrophils, histiocytes and mast cells. Pathol Int. 2002;52(4):277-285. [CrossRef]
  • 5. Araki Y, Andoh A, Fujiyama Y, Bamba T. Development of dextran sulphate sodium-induced experimental colitis is suppressed in genetically mast cell-deficient Ws/Ws rats. Clin Exp Immunol. 2000;119(2):264-269. [CrossRef]
  • 6. Cho EY, Choi SC, Lee SH, et al. Nafamostat mesylate attenuates colonic inflammation and mast cell infiltration in the experimental colitis. Int Immunopharmacol. 2011;11(4):412-417. [CrossRef]
  • 7. Rijnierse A, Koster AS, Nijkamp FP, Kraneveld AD. Critical role for mast cells in the pathogenesis of 2,4-dinitrobenzene-induced murine colonic hypersensitivity reaction. J Immunol. 2006;176(7): 4375-4384. [CrossRef]
  • 8. Hamilton MJ, Sinnamon MJ, Lyng GD, et al. Essential role for mast cell tryptase in acute experimental colitis. Proc Natl Acad Sci U S A. 2011;108(1):290-295. [CrossRef]
  • 9. Iba Y, Sugimoto Y, Kamei C, Masukawa T. Possible role of mucosal mast cells in the recovery process of colitis induced by dextran sulfate sodium in rats. Int Immunopharmacol. 2003;3(4):485-491. [CrossRef]
  • 10. Rigoni A, Bongiovanni L, Burocchi A, et al. Mast cells infiltrating inflamed or transformed gut alternatively sustain mucosal healing or tumor growth. Cancer Res. 2015;75(18):3760-3770. [CrossRef]
  • 11. Zhang H, Xue Y, Wang H, et al. Mast cell deficiency exacerbates inflammatory bowel symptoms in interleukin-10-deficient mice. World J Gastroenterol. 2014;20(27):9106-9115. [CrossRef]
  • 12. Keita ÅV, Söderholm JD. Mucosal permeability and mast cells as targets for functional gastrointestinal disorders. Curr Opin Pharmacol. 2018;43:66-71. [CrossRef]
  • 13. Saez-Lara MJ, Gomez-Llorente C, Plaza-Diaz J, Gil A. The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: a systematic review of randomized human clinical trials. BioMed Res Int. 2015;2015:505878. [CrossRef]
  • 14. Eutamene H, Bueno L. Role of probiotics in correcting abnormalities of colonic flora induced by stress. Gut. 2007;56(11):1495-1497. [CrossRef]
  • 15. Shen J, Zuo ZX, Mao AP. Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn’s disease, and pouchitis: meta-analysis of randomized controlled trials. Inflam Bowel Dis. 2014;20(1):21-35. [CrossRef]
  • 16. Stapleton JR, McClave SA. Controversial results with use of probiotics in critical illness: contradictory findings from large multicenter trial. Curr Gastroenterol Rep. 2009;11(4):259-262. [CrossRef]
  • 17. Abdel-Daim MM, Farouk SM, Madkour FF, Azab SS. Anti-inflammatory and immunomodulatory effects of Spirulina platensis in comparison to Dunaliella salina in acetic acid-induced rat experimental colitis. Immunopharmacol Immunotoxicol. 2015;37(2):126- 139. [CrossRef]
  • 18. Urb M, Sheppard DC. The role of mast cells in the defence against pathogens. PLoS Pathog. 2012;8(4):e1002619. [CrossRef]
  • 19. Douaiher J, Succar J, Lancerotto L, et al. Development of mast cells and importance of their tryptase and chymase serine proteases in inflammation and wound healing. Adv Immunol. 2014;122:211- 252. [CrossRef]
  • 20. Bischoff SC. Mast cells in gastrointestinal disorders. Eur J Pharmacol. 2016;778:139-145. [CrossRef]
  • 21. De Zuani M, Dal Secco C, Frossi B. Mast cells at the crossroads of microbiota and IBD. Eur J Immunol. 2018;48(12):1929-1937. [CrossRef]
  • 22. Söderholm JD, Yang PC, Ceponis P, et al. Chronic stress induces mast cell-dependent bacterial adherence and initiates mucosal inflammation in rat intestine. Gastroenterology. 2002;123(4):1099- 1108. [CrossRef]
  • 23. Chichlowski M, Westwood GS, Abraham SN, Hale LP. Role of mast cells in inflammatory bowel disease and inflammation-associated colorectal neoplasia in IL-10-deficient mice. PLoS ONE. 2010;5(8):e12220. [CrossRef]
  • 24. Lennon EM, Borst LB, Edwards LL, Moeser AJ. Mast cells exert anti-inflammatory effects in an IL10(-/-) model of spontaneous colitis. Mediators Inflam. 2018;2018:1-13. [CrossRef]
  • 25. Bron PA, Kleerebezem M, Brummer RJ, et al. Can probiotics modulate human disease by impacting intestinal barrier function? Br J Nutr. 2017;117(1):93-107. [CrossRef]
  • 26. Bauer O, Razin E. Mast cell-nerve interactions. News in Physiological Sciences: an International Journal of Physiology Produced Jointly by the International Union of Physiological Sciences and the American Physiological Society. 2000;15:213-218.
  • 27. Coskun N, Sindel M, Elpek GO. Mast cell density, neuronal hypertrophy and nerve growth factor expression in patients with acute appendicitis. Folia morphol. 2002;61(4):237-243.
  • 28. Leff AR, Stimler NP, Munoz NM, Shioya T, Tallet J, Dame C. Augmentation of respiratory mast cell secretion of histamine caused by vagus nerve stimulation during antigen challenge. J Immunol. 1986;136(3):1066-1073.
  • 29. Theoharides TC. The mast cell: a neuroimmunoendocrine master player. Int J Tissue React. 1996;18(1):1-21.
  • 30. Lakhan SE, Kirchgessner A. Neuroinflammation in inflammatory bowel disease. J Neuroinflammation. 2010;7:37. [CrossRef]
APA Hizay A, N, Acar N, Comak Gocer E, ŞEKERCİ R, ÖZ N, GOLAL E, Elpek G (2022). Probiotics in Experimental Ulcerative Colitis: Mast Cell Density and Neuronal Hypertrophy. , 822 - 830. 10.5152/tjg.2022.21550
Chicago Hizay Arzu, Nigar,Acar Nuray,Comak Gocer Emine Mine,ŞEKERCİ RAHİME,ÖZ Nuriye,GOLAL EZGİ,Elpek Gulsum Ozlem Probiotics in Experimental Ulcerative Colitis: Mast Cell Density and Neuronal Hypertrophy. (2022): 822 - 830. 10.5152/tjg.2022.21550
MLA Hizay Arzu, Nigar,Acar Nuray,Comak Gocer Emine Mine,ŞEKERCİ RAHİME,ÖZ Nuriye,GOLAL EZGİ,Elpek Gulsum Ozlem Probiotics in Experimental Ulcerative Colitis: Mast Cell Density and Neuronal Hypertrophy. , 2022, ss.822 - 830. 10.5152/tjg.2022.21550
AMA Hizay A, N,Acar N,Comak Gocer E,ŞEKERCİ R,ÖZ N,GOLAL E,Elpek G Probiotics in Experimental Ulcerative Colitis: Mast Cell Density and Neuronal Hypertrophy. . 2022; 822 - 830. 10.5152/tjg.2022.21550
Vancouver Hizay A, N,Acar N,Comak Gocer E,ŞEKERCİ R,ÖZ N,GOLAL E,Elpek G Probiotics in Experimental Ulcerative Colitis: Mast Cell Density and Neuronal Hypertrophy. . 2022; 822 - 830. 10.5152/tjg.2022.21550
IEEE Hizay A, N,Acar N,Comak Gocer E,ŞEKERCİ R,ÖZ N,GOLAL E,Elpek G "Probiotics in Experimental Ulcerative Colitis: Mast Cell Density and Neuronal Hypertrophy." , ss.822 - 830, 2022. 10.5152/tjg.2022.21550
ISNAD Hizay, Arzu vd. "Probiotics in Experimental Ulcerative Colitis: Mast Cell Density and Neuronal Hypertrophy". (2022), 822-830. https://doi.org/10.5152/tjg.2022.21550
APA Hizay A, N, Acar N, Comak Gocer E, ŞEKERCİ R, ÖZ N, GOLAL E, Elpek G (2022). Probiotics in Experimental Ulcerative Colitis: Mast Cell Density and Neuronal Hypertrophy. Turkish Journal of Gastroenterology, 33(10), 822 - 830. 10.5152/tjg.2022.21550
Chicago Hizay Arzu, Nigar,Acar Nuray,Comak Gocer Emine Mine,ŞEKERCİ RAHİME,ÖZ Nuriye,GOLAL EZGİ,Elpek Gulsum Ozlem Probiotics in Experimental Ulcerative Colitis: Mast Cell Density and Neuronal Hypertrophy. Turkish Journal of Gastroenterology 33, no.10 (2022): 822 - 830. 10.5152/tjg.2022.21550
MLA Hizay Arzu, Nigar,Acar Nuray,Comak Gocer Emine Mine,ŞEKERCİ RAHİME,ÖZ Nuriye,GOLAL EZGİ,Elpek Gulsum Ozlem Probiotics in Experimental Ulcerative Colitis: Mast Cell Density and Neuronal Hypertrophy. Turkish Journal of Gastroenterology, vol.33, no.10, 2022, ss.822 - 830. 10.5152/tjg.2022.21550
AMA Hizay A, N,Acar N,Comak Gocer E,ŞEKERCİ R,ÖZ N,GOLAL E,Elpek G Probiotics in Experimental Ulcerative Colitis: Mast Cell Density and Neuronal Hypertrophy. Turkish Journal of Gastroenterology. 2022; 33(10): 822 - 830. 10.5152/tjg.2022.21550
Vancouver Hizay A, N,Acar N,Comak Gocer E,ŞEKERCİ R,ÖZ N,GOLAL E,Elpek G Probiotics in Experimental Ulcerative Colitis: Mast Cell Density and Neuronal Hypertrophy. Turkish Journal of Gastroenterology. 2022; 33(10): 822 - 830. 10.5152/tjg.2022.21550
IEEE Hizay A, N,Acar N,Comak Gocer E,ŞEKERCİ R,ÖZ N,GOLAL E,Elpek G "Probiotics in Experimental Ulcerative Colitis: Mast Cell Density and Neuronal Hypertrophy." Turkish Journal of Gastroenterology, 33, ss.822 - 830, 2022. 10.5152/tjg.2022.21550
ISNAD Hizay, Arzu vd. "Probiotics in Experimental Ulcerative Colitis: Mast Cell Density and Neuronal Hypertrophy". Turkish Journal of Gastroenterology 33/10 (2022), 822-830. https://doi.org/10.5152/tjg.2022.21550